---
category: news
title: "Endeavor BioMedicines Partners with xCures to Identify Patients with PTCH1 mutations for Phase 2 Trial of ENV-101 (taladegib)"
excerpt: "Cures to use tumor sequencing information and its platform to pair patients with available treatment options. Endeavor BioMedicines, a clinical-stage biotechnology company target"
publishedDateTime: 2022-05-31T12:00:00Z
originalUrl: "https://finance.dailyherald.com/dailyherald/article/bizwire-2022-5-31-endeavor-biomedicines-partners-with-xcures-to-identify-patients-with-ptch1-mutations-for-phase-2-trial-of-env-101-taladegib"
webUrl: "https://finance.dailyherald.com/dailyherald/article/bizwire-2022-5-31-endeavor-biomedicines-partners-with-xcures-to-identify-patients-with-ptch1-mutations-for-phase-2-trial-of-env-101-taladegib"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Daily Herald
  domain: dailyherald.com

topics:
  - AI in Healthcare
  - AI

secured: "L8AN9a2nJsFeOWHQApEZKb2+OHC8aIU6vYkvDKYS3bcrMhvrOqp9caBeG0SigztrpXrGVVpKBRyoJ4B6VRkYv2Y8fo5gS2PX6MIQZAWIz19FJNCVGkO6EgyuNt4YDWBPrJGM+XwSF+SWHnHGvorIsFIUOB+CanNcFTPlsj/I3lwtknDdtnW/xgIKC+2qn3iHlQKnZ1h7y50mBoaxgRQZju008VzL0jwOjaVzJyehvqY4QnFhfIaDAOdLJXSffveSX+vv2bodZXYACER9WtTreDdgmYCNkUWi44sUMLw01xb6+MRTbaBVSvN9ZX8qX1FX/29nTEkPS+ls3Or+EklJSQ+OSJR2+EeJqpFvI0/lML4=;KpwY/Kev4fEt4kH3oLWitQ=="
---

